Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae strains

References

• Huang W, Qiao F, Zhang Y, et al. In-hospital medical costs of infections caused by carbapenem-resistant Klebsiella pneumoniae. Clin Infect Dis. 2018;67(suppl_2):S225–S230. doi:10.1093/cid/ciy642
   PubMed Web of Science ®Google Scholar
• Siu LK, Yeh K-M, Lin J-C, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12(11):881–887. doi:10.1016/S1473-3099(12)70205-0
   PubMed Web of Science ®Google Scholar
• Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46. doi:10.1016/S1473-3099(17)30489-9
   PubMed Web of Science ®Google Scholar
• Xie M, Yang X, Xu Q, et al. Clinical evolution of ST11 carbapenem resistant and hypervirulent Klebsiella pneumoniae. Commun biol. 2021;4(1):1–9. doi:10.1038/s42003-020-01566-0
   PubMed Web of Science ®Google Scholar
• Dong N, Lin D, Zhang R, et al. Carriage of bla KPC-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae. J Antimicrob Chemother. 2018;73(12):3317–3321.
   PubMed Web of Science ®Google Scholar
• Dong N, Yang X, Chan EW-C, et al. Klebsiella species: taxonomy, hypervirulence and multidrug resistance. EBioMedicine. 2022;79:103998. doi:10.1016/j.ebiom.2022.103998
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.032
   PubMed Web of Science ®Google Scholar
• Lou T, Du X, Zhang P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: a large multicentre case–control and cohort study. J Infect. 2022;84(5):637–647. doi:10.1016/j.jinf.2022.03.010
   PubMed Web of Science ®Google Scholar
• Sun Q, Yang X, Huang Y, et al. Risk factors and clinical impact associated with infections caused by different types of Carbapenem-resistant Klebsiella pneumoniae in China: a clinical study from 2014∼ 2017. J Infect. 2022;85(4):436-480.
   PubMed Web of Science ®Google Scholar
• Babinchak T, Grosse EE, Dartois N, et al. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005;41(Supplement_5):S354–S367. doi:10.1086/431676
   PubMedGoogle Scholar
• Tanaseanu C, Bergallo C, Teglia O, et al. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;61(3):329–338. doi:10.1016/j.diagmicrobio.2008.04.009
   PubMed Web of Science ®Google Scholar
• McGovern PC, Wible M, El-Tahtawy A, et al. All-cause mortality imbalance in the tigecycline phase 3 and 4 clinical trials. Int J Antimicrob Agents. 2013;41(5):463–467. doi:10.1016/j.ijantimicag.2013.01.020
   PubMed Web of Science ®Google Scholar
• Kang M-S, Lim H-S, Oh J-S, et al. Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus. Pathog Dis. 2017;75(2):ftx009.
   Web of Science ®Google Scholar
• Muhammad Z, Ramzan R, Abdelazez A, et al. Assessment of the antimicrobial potentiality and functionality of Lactobacillus plantarum strains isolated from the conventional inner Mongolian fermented cheese against foodborne pathogens. Pathogens. 2019;8(2):71. doi:10.3390/pathogens8020071
   PubMed Web of Science ®Google Scholar
• Kumar M, Dhaka P, Vijay D, et al. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli. Int J Antimicrob Agents. 2016;48(3):265–270. doi:10.1016/j.ijantimicag.2016.05.014
   PubMed Web of Science ®Google Scholar
• Jamalifar H, Rahimi H, Samadi N, et al. Antimicrobial activity of different Lactobacillus species against multi-drug resistant clinical isolates of Pseudomonas aeruginosa. Iran J Microbiol. 2011;3(1):21.
   PubMedGoogle Scholar
• Chen C-C, Lai C-C, Huang H-L, et al. Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae. J Microbiol Immunol Infect. 2021;54(3):447–456.
   PubMedGoogle Scholar
• Georgieva R, Yocheva L, Tserovska L, et al. Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnol Biotechnol Equip. 2015;29(1):84–91. doi:10.1080/13102818.2014.987450
   PubMed Web of Science ®Google Scholar
• Inglin RC, Stevens MJ, Meile L, et al. High-throughput screening assays for antibacterial and antifungal activities of Lactobacillus species. J Microbiol Methods. 2015;114:26–29. doi:10.1016/j.mimet.2015.04.011
   PubMed Web of Science ®Google Scholar
• Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various bla CTX-M genes. J Antimicrob Chemother. 2006;57(1):14–23. doi:10.1093/jac/dki398
   PubMed Web of Science ®Google Scholar
• Huang Y, Yu X, Xie M, et al. Widespread dissemination of carbapenem-resistant Escherichia coli sequence type 167 strains harboring bla NDM-5 in clinical settings in China. Antimicrob Agents Chemother. 2016;60(7):4364–4368. doi:10.1128/AAC.00859-16
   PubMed Web of Science ®Google Scholar
• Beceiro A, Moreno A, Fernández N, et al. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother. 2014;58(1):518–526. doi:10.1128/AAC.01597-13
   PubMed Web of Science ®Google Scholar
• Siu LK, Fung C-P, Chang F-Y, et al. Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from noninfectious subjects in Hong Kong, Singapore, and Taiwan. J Clin Microbiol. 2011;49(11):3761–3765. doi:10.1128/JCM.00977-11
   PubMed Web of Science ®Google Scholar
• Jadhav S, Hussain A, Devi S, et al. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One. 2011;6(3):e18063. doi:10.1371/journal.pone.0018063
   PubMed Web of Science ®Google Scholar
• Heintz-Buschart A, May P, Laczny CC, et al. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes. Nat microbiol. 2016;2(1):1–13.
   Web of Science ®Google Scholar
• Nurk S, Meleshko D, Korobeynikov A, et al. metaSPAdes: a new versatile metagenomic assembler. Genome Res. 2017;27(5):824–834. doi:10.1101/gr.213959.116
   PubMed Web of Science ®Google Scholar
• Beghini F, McIver LJ, Blanco-Míguez A, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10:e65088. doi:10.7554/eLife.65088
   PubMed Web of Science ®Google Scholar
• Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):1–13. doi:10.1186/s13059-018-1612-0
   PubMed Web of Science ®Google Scholar
• Yan R, Lu Y, Wu X, et al. Anticolonization of Carbapenem-resistant Klebsiella pneumoniae by Lactobacillus plantarum LP1812 through accumulated acetic acid in mice intestinal. Front Cell Infect Microbiol. 2021: 1276.
   Web of Science ®Google Scholar
• Karanika S, Karantanos T, Arvanitis M, et al. Fecal colonization with extended-spectrum beta-lactamase–producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Rev Infect Dis. 2016;63(3):310–318. doi:10.1093/cid/ciw283
   Google Scholar
• Meurs L, Lempp FS, Lippmann N, et al. Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: a cohort study in a German travel clinic (2016–2017). Travel Med Infect Dis. 2020;33:101521. doi:10.1016/j.tmaid.2019.101521
   PubMed Web of Science ®Google Scholar
• Collingwood A, Blostein F, Seekatz AM, et al. Epidemiological and microbiome associations between Klebsiella pneumoniae and vancomycin-resistant Enterococcus colonization in intensive care unit patients. Open Forum Infect Dis. 2020;7(1):ofaa012. Oxford University Press US.
   PubMed Web of Science ®Google Scholar
• Neal-McKinney JM, Lu X, Duong T, et al. Production of organic acids by probiotic lactobacilli can be used to reduce pathogen load in poultry. PLoS One. 2012;7(9):e43928.
   PubMed Web of Science ®Google Scholar
• Tang H-J, Chen C-C, Lu Y-C, et al. The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae. Front Microbiol. 2022;13:1050247. doi:10.3389/fmicb.2022.1050247
   PubMedGoogle Scholar
• Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8(4):260–271. doi:10.1038/nrmicro2319
   PubMed Web of Science ®Google Scholar
• Brockhurst MA, Harrison E. Ecological and evolutionary solutions to the plasmid paradox. Trends Microbiol. 2022;30(6):534-543.
   PubMed Web of Science ®Google Scholar
• Lavigne J-P, Cuzon G, Combescure C, et al. Virulence of Klebsiella pneumoniae isolates harboring bla KPC-2 carbapenemase gene in a Caenorhabditis elegans model. PLoS One. 2013;8(7):e67847. doi:10.1371/journal.pone.0067847
   PubMed Web of Science ®Google Scholar
• Xie M, Chen K, Ye L, et al. Conjugation of virulence plasmid in clinical Klebsiella pneumoniae strains through formation of a fusion plasmid. Adv Biosyst. 2020;4(4):1900239. doi:10.1002/adbi.201900239
   PubMed Web of Science ®Google Scholar
• Jin L, Wang R, Gao H, et al. Identification of a novel hybrid plasmid encoding KPC-2 and virulence factors in Klebsiella pneumoniae sequence type 11. Antimicrob Agents Chemother. 2021;65(6):e02435–20.
   PubMed Web of Science ®Google Scholar
• Bassis CM, Theriot CM, Young VB. Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection. Antimicrob Agents Chemother. 2014;58(5):2767–2774. doi:10.1128/AAC.02262-13
   PubMed Web of Science ®Google Scholar
• Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496–503. doi:10.1016/j.tibtech.2015.06.011
   PubMed Web of Science ®Google Scholar
• El-Mokhtar MA, Hassanein KM, Ahmed AS, et al. Antagonistic activities of cell-free supernatants of lactobacilli against extended-spectrum β-lactamase producing Klebsiella pneumoniae and Pseudomonas aeruginosa. Infect Drug Resist. 2020;13:543.
   PubMed Web of Science ®Google Scholar
• Pettigrew MM, Johnson JK, Harris AD. The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol. 2016;26(5):342–347. doi:10.1016/j.annepidem.2016.02.007
   PubMed Web of Science ®Google Scholar
• Gorrie CL, Mirčeta M, Wick RR, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215. doi:10.1093/cid/cix270
   PubMed Web of Science ®Google Scholar
• Yahav D, Lador A, Paul M, et al. Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother. 2011;66(9):1963–1971. doi:10.1093/jac/dkr242
   PubMed Web of Science ®Google Scholar
• Prasad P, Sun J, Danner RL, et al. Excess deaths associated with tigecycline after approval based on noninferiority trials. Clin Infect Dis. 2012;54(12):1699–1709. doi:10.1093/cid/cis270
   PubMed Web of Science ®Google Scholar
• Cai Y, Wang R, Liang B, et al. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease. Antimicrob Agents Chemother. 2011;55(3):1162–1172. doi:10.1128/AAC.01402-10
   PubMed Web of Science ®Google Scholar
• Du X, He F, Shi Q, et al. The rapid emergence of tigecycline resistance in blaKPC–2 harboring Klebsiella pneumoniae, as mediated in vivo by mutation in tetA during tigecycline treatment. Front Microbiol. 2018;9:648.
   PubMed Web of Science ®Google Scholar
• Dong N, Yang X, Zhang R, et al. Tracking microevolution events among ST11 carbapenemase-producing hypervirulent Klebsiella pneumoniae outbreak strains. Emerg Microbes Infect. 2018;7(1):1–8. doi:10.1038/s41426-018-0146-6
   PubMed Web of Science ®Google Scholar
• Yang X, Sun Q, Li J, et al. Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China. Emerg Microbes Infect. 2022;11(1):841–849. doi:10.1080/22221751.2022.2049458
   PubMed Web of Science ®Google Scholar